| Abstrakt: |
B Results: b Some of the areas developed include medicines distribution, creation of medication records, medicines optimisation (including DRP prevention and solution), medication reconciliation, medicines information, collaborative practice, respect for patient confidentiality and privacy, deprescribing, cost minimisation, and patient education. PDF02.3 Key factors underlying oncology patients' willingness to engage in medication redispensing Lisa-Marie Smale* 1, Toine Egberts2, 3, Rob Heerdink3, 4, Bart van den Bemt5, 6, Charlotte Be... 1Department of Clinical Pharmacy, Radboud Institute for Health Sciences, Radboud university m... B Background and Objective: b Redispensing medication unused by patients could potentially reduce the financial loss and environmental pollution caused by medication waste, particularly for expensive medication such as oral anticancer drugs. All patients had risk factors for VOD: 5 received melphalan, 3 were treated with busulphan and one patient received cyclophosphamide in conditioning regimens; 2 patients were on her second transplantation (one of them had received busulphan on the first one and the second patient had received melphalan); one patient was treated with ifosfamide before transplantation as part of lymphoma treatment. PP035 Clinical pharmacist-led medication reconciliation service in patients with infectious disease... Cüneyd Enver* 1, Buket Ertürk Sengel2, Mesut Sancar1, Volkan Korten2, Betul Okuyan1 1Department of Clinical Pharmacy, Marmara University Faculty of Pharmacy, 2Department of Infe... B Background and Objective: b Clinical pharmacist-led medication reconciliation service could be decreased medication discrepancies which are resulted in medication errors and adverse drug events during transitions of care. [Extracted from the article] |
Full text from SpringerLink